Clinical Trials Logo

Oncology clinical trials

View clinical trials related to Oncology.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06181058 Completed - Oncology Clinical Trials

Escape Room Game in Oncology Nursing

Start date: December 25, 2023
Phase: N/A
Study type: Interventional

This research will be conducted to evaluate the effect of the escape room game activity applied to nursing students taking oncology nursing courses on their academic self-efficacy and critical thinking motivation.

NCT ID: NCT06039670 Completed - Oncology Clinical Trials

Percutaneous Transluminal Forceps Biopsy

Start date: January 2, 2015
Phase:
Study type: Observational [Patient Registry]

To evaluate during a 7 months period the efficacy, safety and accuracy of percutaneous transluminal forceps biopsy combined with transhepatic biliary drainage in patients with biliary stricture

NCT ID: NCT05815056 Completed - Oncology Clinical Trials

Comparaison Between Digital and Drug Induced Sedation in Veinous Access Device Implantation

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare in patients who need an implantation of a veinous access device the sedation with anesthesiologic drugs and with hypnosis using virtual reality material. The main question it aims to answer is: • is hypnosis using virtual reality as safe and powerfull than usual anesthesiologic drugs. Participants will complete a preoperative and postoperative questionnaire. They will be contacted by phone pre and postoperatively. If there is a comparison group: Researchers will compare drug induced sedation and hypnosis induced by virtual reality to see if they are similar in efficacy and sides effects.

NCT ID: NCT05809557 Completed - Oncology Clinical Trials

EMR Chemotoxicity Risk Calculator To Decrease Chemotherapy Toxicity

Start date: January 9, 2023
Phase: N/A
Study type: Interventional

This study will formally test the quality improvement intervention of an EMR based tool that informs medical oncologists visiting a patient for the first time of potential risk of chemotherapy toxicity.

NCT ID: NCT05792891 Completed - Frailty Clinical Trials

Approaches and Metrics in Fraily Patients During COVID-19 Era

COMETA
Start date: December 22, 2020
Phase:
Study type: Observational

The COVID-19 pandemic started in December 2019 in Wuhan, the Chinese province of Hubei. Compared to the period of the first epidemic wave (March to May 2020), in the period of the second epidemic wave (October 2020 to July 2021), deceased people have a more significant clinical complexit, as demonstrated by the higher number of comorbidities.The need to allocate significant amounts of healthcare resources to the COVID-19 emergency, deferral of routine healthcare visits, and invitation to avoid medical controls, if not strictly necessary, may have led to interruptions of disease management undersupply of chronic treatments. Consequently, the health status of patients with chronic pathologic conditions have worsened during and beyond the crisis. Patients with cancer, autoimmune disease, and immune deficiencies represented populations with varying immunocompetence, which made translate into higher susceptibility to SARS-CoV-2 and, for this reason, we defined them as frail populations.The main goal of the study was to propel the field of COVID-19 impact on particularly vulnerable categories of patients. The findings of this study could aid in determining the conditions under which healthcare organizations must operate in the event of a pandemic in order to protect patient's rights to care.

NCT ID: NCT05750199 Completed - Oncology Clinical Trials

The Effectiveness of "Multi-Immunotherapy Special Training Courses Through Digital Media and Workshop" Intervention for Oncology Nurses: Exploration of Educational Needs, Curriculum Planning, Implementation and Evaluation

Start date: April 28, 2021
Phase: N/A
Study type: Interventional

This study is a 2-year qualitative and quantitative mixed method research project and consists of two phases.The study will provide useful clinical data to help us better understand educational needs of immunotherapy for oncology nurses. This ISTC model will lead to further validation of an oncology care training course model designed to better prepare and support cancer patients and their families to existing and new anti-cancer therapies.

NCT ID: NCT05607186 Completed - Rectal Cancer Clinical Trials

Outcomes of Neoadjuvant Therapy for Rectal Cancer in a Tertiary Asian Institute

Start date: January 1, 2011
Phase:
Study type: Observational

This is a retrospective cohort study that aims to evaluate the correlation of magnetic resonance tumour regression grade (mrTRG) and pathological TRG (pTRG) of locally advanced rectal cancer after neoadjuvant long course chemoradiotherapy as well as the prognostic value of mrTRG on survival.

NCT ID: NCT05518825 Completed - Oncology Clinical Trials

Assessment of ONS-flavour Preference in Cancer Patients With and Without Taste Alterations

PREFER
Start date: October 6, 2022
Phase: N/A
Study type: Interventional

A single arm intervention study examining ONS-flavour preference in cancer patients with and without taste alterations

NCT ID: NCT05493306 Completed - Oncology Clinical Trials

Evaluation of Telerehabilitation Following Inpatient or Outpatient Rehabilitation Phase II

Start date: April 8, 2021
Phase:
Study type: Observational

Telerehabilitation is implemented in the Pensionsversicherungsanstalt (PVA) as an independent rehabilitation offer following a rehabilitation phase II. This offer primarily includes physiotherapeutic training units in group settings and in individual counselling, as well as health-related educational sessions and doctor's consultations via video conferencing, initially for rehabilitation patients with diseases of the musculoskeletal system or oncological diseases. The first stage of the implementation process was evaluated with a focus on acceptance, usability and feasibility from the perspective of patients and treatment team. The evaluation was based on a convergent mixed methods design (Creswell & Plano Clark, 2017) to draw on the strengths of qualitative and quantitative research approaches (Creswell & Creswell, 2018). Qualitative and quantitative data were generated in parallel and treated equally. The perspective of the patients (N = 86) was collected through online questionnaires and in-depth telephone interviews (N = 22) and that of the treatment team through a questionnaire survey (N = 32) and focus group interviews (N = 24). The administrative team (N = 8) was asked for their assessment in a focus group interview. Technical difficulties in the implementation of telerehabilitation were documented by the treatment team. The consolidation of these multi-perspective results took place at the level of interpretation.

NCT ID: NCT05478135 Completed - Oncology Clinical Trials

A Remote Evaluation of NAVIFY Oncology Hub Using Clinical Simulation

Start date: May 15, 2022
Phase: N/A
Study type: Interventional

This work seeks to understand current clinical workflow practice and validate use cases for NAVIFY Oncology Hub. The main purpose of NAVIFY Oncology Hub is to enhance clinical and operational effectiveness, from diagnostic workup to treatment planning and management. This might free up providers' time and capacity to provide better and more personalized care to patients. This research protocol builds on previous work that validated clinical simulation methods as a means for clinicians to generate useful insights during the testing and development of digital health tools (Gardner et al. 2020). Accordingly, this study aims to test the ability of NAVIFY Oncology Hub to increase the work efficiency of oncologists and reduce the cognitive burden/mental fatigue associated with patient care and decision-making. The insights generated will be used to guide the development of NAVIFY Oncology Hub and optimise user experience, as well as provide a better understanding of the opportunities for it to have maximal impact in the decision-making process.